ROWLAND CHARLES A JR sold 35.7% of their position (8.50K shares) of NABRIVA THERAPEUTICS PLC on the open market
Open‑market sale worth $1.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/3/2022ACC: 0001104659-22-085790
Director
Since Aug 2018
-8.50K
Net shares
Net seller
$1.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.50K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−8.50K
Price / share
$0.17
Trade value
$1.49K
% of position
35.7%
8/1/2022
23.77K→15.28K
Total
Net shares
−8.50K
Net value
-$1.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/1/2022 | S · Sale | −8.50K | $0.17 | $1.49K | 35.7% | 23.77K | 15.28K |
| Total | −8.50K | -$1.49K | ||||||
Derivative Transactions0
No derivative transactions reported